Johns Hopkins University
3400 North Charles Street
663 articles with Johns Hopkins University
Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
Candel Therapeutics, a clinical-stage biotechnology company developing novel immune-based cancer therapeutics, announced the initial formation of its Research Advisory Board with the appointment of James Allison, Ph.D., Henry Brem, M.D., Roy S. Herbst, M.D., Ph.D., Elizabeth Jaffee, M.D., Philip Kantoff, M.D., and Padmanee Sharma, M.D., Ph.D., who will join existing scientific advisor and board member Edward Benz, M.D.
A naturally occurring system for tuning CRISPR-Cas9 expressing in bacteria, identified in a study published in Cell, could have implications for gene editing therapies as well.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 3, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
Leading global experts contributed to the report, which offers clear guidance and recommendations on ethics and governance as digital technologies are developed to fight the pandemic
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 19, 2020.
Foundation for Sarcoidosis Research and University of Cincinnati Share Initial Results of COVID-19 Impact Survey
COVID-19 has changed our world. As of April 27, 2020, the Johns Hopkins University Coronavirus Resource Center reported over 3 million cases of COVID-19 worldwide, including 979,077 in the United States.
Adds New Data to Comprehensive Online Resource Center Bloomberg Philanthropies, Stavros Niarchos Foundation Provide Critical Funding to Develop and Expand This Work COVID-19 Resource Center Website Now Tracking U.S. Testing Efforts and Providing Expert Analysis.
CareDx and Johns Hopkins Announce Mobile Health Partnership with RemoTraC Use Among Lung Transplant Patients
What can the public do to defend against the COVID-19 coronavirus? One simple answer is to ramp up humidification at home and in the workplace, if humidity levels are low.
Capsulomics establishes $3.7 Million NIH-funded research collaboration with Johns Hopkins University
In collaboration with JHU, Capsulomics will advance pre-cancer and cancer-detection technology licensed in 2019
Top Doctors Limit Number of Tests They Order for Patients to Signal Level of Diagnostic Prowess to Peers, Study Says
Some expert medical diagnosticians may limit the number of patient tests they order, as a way to signal a high level of competence to their peers, according to a Johns Hopkins University study.
MMAAP Foundation Announces China's Dalian Fusheng Pharmaceutical Company Co., Ltd. Makes Second Contribution in 2019 to Fund Research in Aging and Immunity Sponsored by the Irma and Paul Milstein Program
Dalian Fusheng Pharmaceutical Company Co., Ltd., a major pharmaceutical company in Dalian, China has contributed $100,000 to the Milstein Medical Asian American Partnership Foundation to support translational research at Johns Hopkins University focusing on aging immune system and viral infections.
Their work has helped in the development of new medications to fight anemia, cancer and many other diseases.
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
AxoSim Licenses Revolutionary Mini-Brain Technology from Johns Hopkins University Enabling the Use of Human Data to Speed New Drug Research
AxoSim, Inc. announced an exclusive license from Johns Hopkins University to intellectual property underlying the "Mini-Brain" technology, which uses induced pluripotent stem cells to create functional models of the human brain.
Thrive Earlier Detection Corp., a liquid biopsy company, raised $110 million in Series A funding. The company is launching CancerSEEK, a liquid biopsy test to detect multiple cancers early.
New Lustgarten-Funded Research Develops Artificial Intelligence Methods to Detect Pancreatic Cancer Earlier
Lustgarten Foundation funded researchers at Johns Hopkins University have released promising results showing that computers can be trained to detect pancreatic tumors in CT scans, as reported in the American Journal of Roentgenology.
Paramount Pictures Executive Wyck Godfrey and Mary Kerr, MD, MPH, Actor Zoe Saldana-Perego and Artist Marco Perego-Saldana receive global humanitarian awards at Jhpiego event
Hollywood turned out Monday night to honor couples Actor Zoe Saldana-Perego and Artist Marco Perego-Saldana and Paramount Pictures' Wyck Godfrey and Dr. Mary Kerr for their support of quality health care for women and their families wherever they live—the global mission of Jhpiego, an affiliate of Johns Hopkins University.